Fuse develops and manufactures innovative diagnostic products for a range of industries delivering lab quality information wherever it is needed through ultra-rapid, low-cost tests.

The immunoassay and PCR technologies that dominate the diagnostics industry have consistently failed to deliver lab-quality tests that are suitable for widespread decentralised use.  Using an all-new multianalytic chemistry and breakthrough product innovations Fuse has overcome the cost and performance challenges of established approaches to make accurate, point-of-need testing a reality for all.

Fuse Diagnostics

Following hot on the heels of our £1.6m seed round we are pleased to further announce a $1m Carb-X backed programme using our technology platforms to develop a CT/NG test to help in the fight against antimicrobial resistance. 💥 🎉 

https://fuse-dx.com/news

CARB-X will award US$1 million to Fuse Diagnostics to demonstrate proof-of-concept and feasibility ahead of the development of a rapid, instrument-free diagnostic for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). 
 
Gonorrhea, caused by Neisseria gonorrhoeae, is the second-most reported bacterial sexually transmitted infection, infecting approximately 82 million people globally in 2020. Patients with gonorrhea may experience serious health effects, including pelvic inflammatory disease, chronic pain, and infertility. Untreated gonorrhea can spread to the blood stream, which can be life threatening, and increase the risk of HIV infection. 
 
The award will fund the demonstration of performance of Fuse's CT/NG test, Apex, on clinical samples. Apex CT/NG utilizes innovative device designs and molecular technologies with the potential to deliver accuracy that is equivalent to lab-based PCR systems in an ultra-rapid, low-cost format ideally suited to flexible global deployment, including areas with remote access to secondary healthcare in low- and middle-income countries (LMICs). 
 
🔗 Read more: bit.ly/3VmwmXp 

#AMR #StopSuperBugs #SuperBugs #AntibioticResistance #Medicine #GlobalHealth #Innovation #Biotechnology #LMICs #antibiotics 

Boston University School of Law Boston University Biomedical Advanced Research and Development Authority (BARDA) HHS Administration for Strategic Preparedness and Response National Institute of Allergy and Infectious Diseases (NIAID) Wellcome Trust Bundesministerium für Bildung und Forschung Bill & Melinda Gates Foundation Government of Canada Novo Nordisk Foundation Centre for Cellular and Molecular Platforms (C-CAMP) FIND German Center for Infection Research Institute For Life Science Entrepreneurship (ILSE)

Lucira Pfizer is a company focused on developing and commercializing infectious disease testing solutions, including molecular diagnostics.

Lucira Pfizer

Fluxergy is a company specializing in the development of rapid molecular diagnostic testing platforms for various applications.

Fluxergy

My110 is a company that focuses on developing innovative diagnostic tests for various medical applications, including molecular diagnostics.

My110

Luas Diagnostics is a company specializing in the development of advanced molecular diagnostic solutions for healthcare applications.

Luas Diagnostics

Oxsed is a company focused on the development of rapid and accurate diagnostic solutions, including molecular diagnostics, for infectious diseases.

Oxsed

DxLab is a company specializing in the development of molecular diagnostic testing platforms and solutions for various medical applications.

DxLab

BioHermes is a company that focuses on the development and commercialization of molecular diagnostic tools and solutions for healthcare applications.

BioHermes

VIRIS Detection Systems is a company specializing in the development of advanced molecular diagnostic systems for the detection of infectious diseases.

VIRIS Detection Systems

Fuse Diagnostics is a company specializing in the development of innovative, rapid, low-cost diagnostic tests that bridge the gap between laboratory-based and point-of-need testing.

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	Jul 4, 2024 10:48 PM	723760f2
public peers	general	Jul 3, 2024 10:09 PM	37f4b31f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 3, 2024 10:14 PM	275d254d
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general	Jul 3, 2024 10:09 PM	205779d2
news basic	general	Jul 3, 2024 10:09 PM	883ee53c
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:FUSE-DX

Fuse Diagnostics